We have made significant strides with our pipeline and Klarity™ Platform, thanks to the work of our internal team of intrepid scientists and our enabling and drug discovery collaborations. We thrive on bringing together diverse perspectives from both inside and outside of our company.
As we continue to unlock the transformative potential of the gut-brain axis to create innovative medicines, we are particularly interested in industry or academic collaborations that further enable the understanding of gut/brain targets, the gut-brain axis, and intersecting chemical matter in the following key therapeutic areas:
Metabolism
Gastrointestinal
Disease
Neurological
Disorders
Kallyope leads the industry in understanding the gut-brain axis, and we are excited to combine their scientific expertise with our world-leading G protein-coupled receptor platform to identify and validate novel targets for potential in treating gastrointestinal disease, a key area of focus for our company.
Matt Barnes, Head of UK Research and Development, Sosei Heptares
Partner With Us
If you are interested in partnering with us, please email Robert Barretto, PhD, at
